RB Global, Inc. (NYSE:RBA) Receives $116.21 Consensus PT from Analysts

Shares of RB Global, Inc. (NYSE:RBA – Get Free Report) (TSE:RBA) have been given a consensus recommendation of “Moderate Buy” by the seven analysts that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. […]

Leave a Reply

Your email address will not be published.

Previous post Analysts Set MoonLake Immunotherapeutics (NASDAQ:MLTX) Price Target at $73.14
Next post WAVE Life Sciences Ltd. (NASDAQ:WVE) Receives $20.43 Consensus PT from Analysts